Ultraviolet radiation induces p16(CDKN2A) expression in human skin

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4185-4189

  Pavey, Sandra ^b   Conroy, Sinead ^b   Russell, Terry ^b   Gabrielli, Brian ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16;

ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KERATINOCYTE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; G2 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; SKIN; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0033200066     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Foulkes, W. D., Flanders, T. Y., Pollock, P. M., and Hayward, N. K. The CDKN2A (p16) gene and human cancer. Mol. Med., 3: 5-20, 1997.
2. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta, 137: 115-177, 1998.
3. Castellano, M., Pollock, P. M., Walters, M. K., Sparrow, L. E., Down, L. M., Gabrielli, B. G., Parsons, P. G., and Hayward, N. K. CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res., 57: 4868-4867, 1997.
4. Pollock, P. M., Pearson, J. V., and Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15: 77-88, 1996.
5. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8: 2939-2952, 1994.
6. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375: 503-506, 1995.
7. Koh, J., Enders, G. H., Dynlacht, B. D., and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
8. INK4a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.
9. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
10. INK4 expression. Oncogene, 13: 1259-1268, 1996.
11. INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res., 58: 3508-3512, 1998.
12. Ink4. Cancer Res., 54: 5816-5820, 1994.
13. Wang, Y., and Becker, D. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. Oncogene, 12: 1069-1075, 1996.
14. 2-phase cell cycle delay. Cancer Res., 56: 2510-2514, 1996.
15. Milligan, A., Gabrielli, B. G., Clark, J. M., N. K., H., and Ellem, K. A. O. Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation. Mutat. Res., 422: 43-53, 1998.
16. Peak, M. J., and Peak, J. G. Solar-ultraviolet-induced damage to DNA. Photodermatol., 6: 1-15, 1989.
17. Campbell, C., Quinn, A. G., Angus, B., Farr, P. M., and Rees, J. L. Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res., 53: 2697-2699, 1993.
18. Fitzpatrick, T. B., and Szabo, G. The melanocyte: cytology and cytochemistry. J. Invest. Dermatol., 32: 197, 1959.
19. Wang, X. Q., and Ellem, K. A. Heterogeneity in the HeLa cell cycle response to UVC analyzed by the BrdUrd two-parameter method. Exp. Cell Res., 212: 176-189, 1994.
20. INK4 proteins in cutaneous malignant melanoma. Br. J. Dermatol., 134: 269-275, 1996.
21. Takahashi, H., and Parsons, P. G. In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression. Pigm. Cell Res., 3: 223-232, 1990.
22. Hall, P. A., McKee, P. H., Menage, H. D., Dover, R., and Lane, D. P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8: 203-207, 1993.
23. Ponten, F., Berne, B., Ren, Z. P., Nister, M., and Ponten, J. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J. Invest. Dermatol., 105: 402-406, 1995.
24. Ueda, M., Ahmed, N. U., Bito, T., Nagano, T., and Ichihashi, M. The expression of retinoblastoma protein in epidermis is induced by ultraviolet B exposure. Br. J. Dermatol. 135: 406-411, 1996.
25. Sage, E. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol., 57: 163-174, 1993.
26. Stein, G. H., Drullinger, L. F., Soulard, A., and Dulic, V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19: 2109-2117, 1999.
27. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (Lond.), 396: 84-8, 1998.
28. 2 phase delay. J. Biol. Chem., 274: 13961-13969, 1999.
29. Kraemer, K. H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad, Sci. USA, 94: 11-4, 1997.
30. Campbell, C., Quinn, A. G., Angus, B., and Rees, J. L. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br. J. Dermatol., 129: 235-241, 1993.
31. Jonason, A. S., Kunala, S., Price, G. J., Restifo, R. J., Spinelli, H. M., Persing, J. A., Leffell, D. J., Tarone, R. E., and Brash, D. E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA, 93: 14025-14029, 1996.
32. Waf-1/SDI-1/Cip-1 protein. Cancer Res., 55: 4047-4052, 1995.
33. Albino, A. P., Vidal, M. J., McNutt, N. S., Shea, C. R., Prieto, V. G., Nanus, D. M., Palmer, J. M., and Hayward, N. K. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res., 4: 35-45, 1994.
34. Stretch, J. R., Gatter, K. C., Ralfkiaer, E., Lane, D. P., and Harris, A. L. Expression of mutant p53 in melanoma. Cancer Res., 51: 5976-5979, 1991.
35. Smith, M. L., and Fornace, A. J., Jr. p53-mediated protective responses to UV irradiation. Proc. Natl. Acad. Sci. USA, 94: 12255-12257, 1997.